Please check the following:
- {{error.value}}
FREE membership
FREE membership
Join InvestSMART today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Start your free 15 day trial now' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
OR
Sign up with
Login with
By continuing, you agree to our
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
Looks you are already a member. Please enter your password to proceed
OR
Sign up with
Login with
By continuing, you agree to our
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
OR
Sign up with
Login with
By continuing, you agree to our
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Check your inbox
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
Proteomics International Laboratories Ltd (ASX:PIQ)
ALERT: Price-sensitive ASX Announcement for PIQ
Current share price for PIQ : $0.160 -0.105 (-39.62%)+
Announcement
Release
28 Apr 2026 8:59AM
Price at Release
$0.265
Full Release
Summary
Proteomics International Laboratories Ltd, known for leveraging its expertise in proteomics, has outlined its strategic plan focusing on the expansion and commercialization of its diagnostic tests. The company's strategic roadmap through 2029 includes key goals such as appointing distributor partners in Australia and the USA, optimizing laboratory processes, and securing reimbursement frameworks for its tests. Proteomics International intends to broaden its distributor network, increase test utilization across clinical indications, and expand laboratory capacity. The innovation portfolio includes diagnostic tests like Promarker D, Promarker Eso, and Promarker Endo, which target diseases such as diabetes-related chronic kidney disease, oesophageal cancer, and endometriosis. The company aims to deliver sustainable value by enhancing commercial execution, optimizing operations, and strengthening organizational capabilities.
Key Points
- Appoint distributor partners in Australia and the USA.
- Optimize test turnaround times and customer experience.
- Expand laboratory capacity in line with demand.
- Focus on reimbursement strategies for Australia and the USA.
- Leverage proteomics expertise for clinically validated tests.
- Secure reimbursement through private pay and public funding.
- Develop strategic growth options for product and geographic expansion.
- Prioritize commercial growth and validated product performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
